Do GST Gene Variants Affect Lung Cancer Risk?
Author Information
Author(s): Zheng Ye
Hypothesis
Do variants in the GST detoxification genes affect the risk of lung cancer?
Conclusion
The study found no significant associations between the five GST polymorphisms and lung cancer risk in the general population.
Supporting Evidence
- The study analyzed data from 130 published studies on GST alleles and lung cancer.
- Neither the I105V nor A114V polymorphisms were associated with lung cancer risk.
- The GSTM1 and GSTT1 null polymorphisms showed a weak association with lung cancer.
- Restricting analysis to larger studies resulted in no significant associations.
- The findings suggest that the five polymorphisms do not significantly increase lung cancer risk.
Takeaway
The study looked at whether certain genes related to detoxifying harmful substances affect lung cancer risk, and it found that they probably don't.
Methodology
A meta-analysis of 130 studies examining associations between five GST alleles and lung cancer.
Potential Biases
There is a risk of bias due to the tendency to publish positive results, especially from smaller studies.
Limitations
The study's results may be influenced by publication bias and the analysis was limited to larger studies.
Participant Demographics
The study included 23,452 lung cancer cases and 30,397 controls.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website